Artfun+ by Imageens wins the Europeen EIT Health Grant
Imageens, a French leading startup in medical technology, has been awarded the prestigious EIT Health grant for its cutting-edge solution, Artfun+. This revolutionary technology plays a pivotal role in the CMRAI project in partnership with Sorbonne University and Siemens, aiming to revolutionize precision cardiovascular medicine in aortic aneurysm through advanced MRI techniques.
Imageens’ Artfun+ solution harnesses the power of advanced MRI imaging to meticulously examine the aorta, unveiling subtle vulnerabilities that might go unnoticed by measuring precision biomarkers. With unparalleled precision, Artfun+ empowers medical professionals to make informed decisions, provide personalized care, and reshape cardiovascular medicine.
The CMRAI (Cardiovascular Magnetic Resonance for Aortic Imaging) project enhances aneurysm aortic assessments, enabling early identification of high-risk patients for more effective interventions.
This game-changing recognition is not only acknowledging the ingenuity and dedication of the Imageens team but also underscores the significance of the CMRAI project in advancing healthcare and saving lives propelling the project forward and reinforcing the importance of investing in cutting-edge technologies that have the power to redefine medical practices.
About Imageens:
Imageens is a Paris-based Healthtech company founded in 2017, focusing on the prevention and early diagnosis of cardiovascular diseases (CVD). Since its inception, Imageens has been immersed in international DeepTech and established with the goal of developing market-ready medical image processing software based on over 10 years of technical and clinical research conducted by world-class research institutions such as Sorbonne Université, the AP-HP, and Johns Hopkins. From the outset, Imageens has demonstrated its capability to harness advanced AI in creating cutting-edge medical software. This innovation has earned recognition through several prestigious French innovation competitions and multiple innovation labels. Today, Imageens leads the charge in the rapidly growing field of AI in cardiovascular health and medical imaging. The company possesses the world’s most clinically validated technology for analyzing arterial function through MRI, deploying this technology alongside other AI components to revolutionize treatment decisions in cardiovascular health and beyond. www.imageens.com.
About CMRAI Project:
The objective of the CMRAI project is to create a platform that will make it possible to define, from the first signs of the disease, an aortic aneurysm risk score for each patient, and therefore to define a personalized follow-up and management strategy.
